Histogen
San Diego
About Histogen
Histogen is a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body. The company’s innovative technology platform utilizes cell-conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products that address underserved, multi-billion US dollar global markets. It was founded in 2007 by Dr. Gail Naughton and is headquartered in San Diego, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $87.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2022)
- Ticker: nasdaq:HSTO
- Website: histogen.com
- Phone: (858) 200-9520
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/histogen-152246 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.